Porton Pharma Solutions surged more than 15%, Asymchem Laboratories is close to hitting the limit up, with Nosgen, Haoyuan Pharma, Joinn Laboratories, shanghai medicilon inc., and others leading the gains. On the news front, Porton Pharma Solutions' third-quarter report shows that as of the end of September, the company's small molecule active pharmaceutical ingredient CDMO business saw an increase of more than 40% in unexecuted orders compared to the same period last year. Therefore, based on the pace of order deliveries, the company maintains its guidance for year-on-year revenue growth (excluding substantial orders) to remain positive.